These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21068050)

  • 1. Neuromuscular dose-response studies: determining sample size.
    Kopman AF; Lien CA; Naguib M
    Br J Anaesth; 2011 Feb; 106(2):194-8. PubMed ID: 21068050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the potency of neuromuscular blockers: are traditional methods flawed?
    Kopman AF; Lien CA; Naguib M
    Br J Anaesth; 2010 Jun; 104(6):705-10. PubMed ID: 20430764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical points in understanding neuromuscular blockade.
    Steckbar T
    J Post Anesth Nurs; 1990 Oct; 5(5):350-3. PubMed ID: 2213630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
    Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
    Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the potency of neuromuscular blockers.
    Fisher D
    Br J Anaesth; 2010 Oct; 105(4):544; author reply 544-5. PubMed ID: 20837723
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of neuromuscular blockade in the critically ill patient.
    Michaud D; Abbas M; Gélinas C
    Dynamics; 2002; 13(3):11. PubMed ID: 12640839
    [No Abstract]   [Full Text] [Related]  

  • 7. Mastering neuromuscular blockade.
    Arbour R
    Dimens Crit Care Nurs; 2000; 19(5):4-16; quiz 17-20. PubMed ID: 11998066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of neuromuscular block: time for a change?
    Mirakhur RK; Harrop-Griffiths W
    Anaesthesia; 2009 Mar; 64 Suppl 1():iv-v. PubMed ID: 19222425
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of neuromuscular blockade in the critically ill patient.
    Burry L; HoSang M; Hynes-Gay P
    Dynamics; 2001; 12(3):28-33; quiz 34-5. PubMed ID: 11982205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceleromyography and mechanomyography for establishing potency of neuromuscular blocking agents: a randomized-controlled trial.
    Claudius C; Skovgaard LT; Viby-Mogensen J
    Acta Anaesthesiol Scand; 2009 Apr; 53(4):449-54. PubMed ID: 19317862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclic cucurbit[n]uril-type molecular containers bind neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo.
    Ma D; Zhang B; Hoffmann U; Sundrup MG; Eikermann M; Isaacs L
    Angew Chem Int Ed Engl; 2012 Nov; 51(45):11358-62. PubMed ID: 23047893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring neuromuscular block: an update.
    Fuchs-Buder T; Schreiber JU; Meistelman C
    Anaesthesia; 2009 Mar; 64 Suppl 1():82-9. PubMed ID: 19222435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular blocking drugs and their antagonists in patients with organ disease.
    Craig RG; Hunter JM
    Anaesthesia; 2009 Mar; 64 Suppl 1():55-65. PubMed ID: 19222432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The undesirable effects of neuromuscular blocking drugs.
    Claudius C; Garvey LH; Viby-Mogensen J
    Anaesthesia; 2009 Mar; 64 Suppl 1():10-21. PubMed ID: 19222427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuromuscular junction: pharmacology, toxicology and clinical use of neuromuscular blocking agents].
    Conte-Camerino D; Siro-Brigiani G
    Clin Ter; 1975 Mar; 72(5):461-91. PubMed ID: 773593
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuromuscular blockade in adult intensive care.
    Topulos GP
    New Horiz; 1993 Aug; 1(3):447-62. PubMed ID: 7922424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response relation, neuromuscular blocking action, intubation conditions, and cardiovascular effects of Org 9273, a new neuromuscular blocking agent.
    van den Broek L; Lambalk LM; Richardson FJ; Wierda JM
    Anesth Analg; 1991 Jun; 72(6):811-6. PubMed ID: 1674648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual neuromuscular blockade in critical care.
    Wilson J; Collins AS; Rowan BO
    Crit Care Nurse; 2012 Jun; 32(3):e1-9; quiz e10. PubMed ID: 22661165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.
    Kirov K; Motamed C; Decailliot F; Behforouz N; Duvaldestin P
    Acta Anaesthesiol Scand; 2004 May; 48(5):577-81. PubMed ID: 15101851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.